San Francisco Sentry Investment Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
San Francisco Sentry Investment Group's LLY Position: Q2 2021 in Review
San Francisco Sentry Investment Group reduced its Eli Lilly (LLY) stake by 7% in Q2 2021, selling an estimated $15.1K and leaving 993 shares worth $228K. The position accounts for 0.12% of the portfolio, ranked #185.
San Francisco Sentry Investment Group first reported a position in LLY in Q2 2013 and has held it in 23 quarters since. The position peaked at $7.44M in Q1 2014. 2,022 funds tracked by Wall St. Rank hold LLY as of Q2 2021.
- San Francisco Sentry Investment Group held 993 shares of Eli Lilly worth $228K as of Q2 2021.
- San Francisco Sentry Investment Group sold 75 Eli Lilly shares in Q2 2021, an estimated $15.1K.
- Eli Lilly made up 0.12% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #185 holding.
- San Francisco Sentry Investment Group first reported a position in Eli Lilly in Q2 2013 and has held it in 23 quarters since.
- San Francisco Sentry Investment Group's Eli Lilly position peaked at $7.44M in Q1 2014.
- 2,022 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2021.
Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.